Holen Sie sich die Stockscreener-App
7.475
3.93%
-0.295
Adaptive Biotechnologies Corp Aktie (ADPT) Neueste Nachrichten
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Stock Sentiment: What’s Wall Street Saying? - Stocksregister
What technical indicators reveal about ADPT stock - uspostnews.com
Renaissance Technologies LLC Increases Stock Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - American Banking and Market News
Renaissance Technologies LLC Buys 60,385 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
XTX Topco Ltd Buys Shares of 29,585 Adaptive Biotechnologies Co. (NASDAQ:ADPT) - American Banking and Market News
Legal & General Group Plc Buys 97,798 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Stock Performance Spotlight: Adaptive Biotechnologies Corp (ADPT) Ends the Day at 7.90, Up by 0.13 - DWinneX
Trading Day Review: Adaptive Biotechnologies Corp (ADPT) Loses Momentum, Closing at 7.66 - DWinneX
Adaptive Biotechnologies Corp [ADPT] Shares Rise 6.91 % on Thursday - knoxdaily.com
Adaptive Biotechnologies Corp (NASDAQ:ADPT) Could Really Rise To 18 In 12 Months, According To Analysts. - Marketing Sentinel
Adaptive Biotechnologies Corp: Weathering Stock Market Storms with 1.17B Market Cap - investchronicle.com
Cathie Wood’s ARK Sells Adaptive Biotech, Buys Beam Therapeutics Stock - Investing.com
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Shares Acquired by Russell Investments Group Ltd. - Defense World
Cathie Wood Buys More NVIDIA And AMD Stock As Chinese Tech Giants Stockpile Chips Amid Looming US Export CurbsAdvanced Micro Devices (NASDAQ:AMD), Adaptive Biotechnologies (NASDAQ:ADPT) - Benzinga
LPL Financial LLC Sells 8,470 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Why Calix Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Insider ROBINS HARLAN S sells 1,698 of Adaptive Biotechnologies Corp [ADPT] Stock - knoxdaily.com
JPMorgan Chase & Co. Lowers Stock Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Alliancebernstein L.P. Sells 1,890 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Federated Hermes Inc. Reduces Stock Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Franklin Resources Inc. Invests $443,000 in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025 | ADPT Stock News - GuruFocus
Corebridge Financial Inc. Has $345,000 Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025 - The Manila Times
25,800 Shares in Adaptive Biotechnologies Co. (NASDAQ:ADPT) Acquired by KLP Kapitalforvaltning AS - Defense World
Adaptive Biotechnologies' Mantle Cell Lymphoma Test Receives Expanded Medicare Coverage - MarketScreener
Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma - The Manila Times
Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - GlobeNewswire Inc.
Adaptive Biotechnologies Receives Expanded Medicare - GlobeNewswire
Guess, Tesla, Nvidia And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Why Sangamo Therapeutics Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Adaptive Biotechnologies Corp (ADPT) Forecasts And Estimates For The Near Future - Marketing Sentinel
Swiss National Bank Takes $1.22 Million Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Proficio Capital Partners LLC Takes Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Adaptive Biotechnologies Corp: Analyzing ADPT Stock Trends - investchronicle.com
Adaptive Biotechnologies (NASDAQ:ADPT) Hits New 12-Month HighShould You Buy? - MarketBeat
Adaptive Biotechnologies’ chief scientific officer sells shares for $15,282 By Investing.com - Investing.com Australia
Adaptive Biotechnologies’ chief scientific officer sells shares for $15,282 - Investing.com India
Charles Schwab Investment Management Inc. Acquires 39,831 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Adaptive Biotechnologies stock hits 52-week high at $8.95 By Investing.com - Investing.com Australia
Adaptive Biotechnologies stock hits 52-week high at $8.95 - Investing.com
Amundi Boosts Stake in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Up – What’s Next? - Defense World
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Rating Upgraded by The Goldman Sachs Group - Defense World
Bank of New York Mellon Corp Has $2.18 Million Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Adaptive Biotechnologies Gains Following Goldman Sachs Upgrade, Share Climb 6% Near Friday Close - MarketScreener
Analyst Expectations For Adaptive Biotechnologies's Future - Benzinga
Scholastic Posts Strong Earnings, Joins Ouster, Torrid Holdings, Adaptive Biotechnologies And Other Big Stocks Moving Higher On Friday - Benzinga
Goldman Sachs Upgrades Adaptive Biotechnologies to Buy From Neutral, Adjusts Price Target to $9 From $8 - Marketscreener.com
Adaptive Biotechnologies Corp (NASDAQ: ADPT): What It’s Worth And What To Do About It - Marketing Sentinel
Adaptive Biotechnologies (ADPT): Among Stocks Insiders Are Selling In March - Insider Monkey
10 Stocks Insiders Are Selling In March - Insider Monkey
Proficio Capital Partners LLC Takes $93,000 Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Critical Survey: Adaptive Biotechnologies (NASDAQ:ADPT) vs. Beam Therapeutics (NASDAQ:BEAM) - Defense World
Adaptive Biotechnologies director sells shares worth $70,500 By Investing.com - Investing.com Canada
Adaptive Biotechnologies director sells shares worth $70,500 - Investing.com India
Adaptive Biotechnologies director sells shares worth $402,270 - Investing.com
1.36%
0.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):